INVESTORS

INVESTORS

Corporate Profile

Xtant Medical Holdings, Inc. (NYSE MKT: XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries.

Sean Browne, Xtant Medical President and CEO, Interviewed by Proactive Investors

 

 

 

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Stock Chart

Recent News

Date Title  
Toggle Summary Xtant Medical Announces Fourth Quarter and Full Year 2022 Financial Results
BELGRADE, Mont. , March 07, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the fourth quarter and year ended
Toggle Summary Xtant Medical to Issue Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023
BELGRADE, Mont. , March 03, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and
Toggle Summary Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million
Expands Xtant’s Product Offering with the Leading PMA-Approved Intralaminar Stabilization Device Strengthens Surgalign’s Balance Sheet as it Embarks on its Digital Health Strategy BELGRADE, Mont. and DEERFIELD, Ill. , March 01, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc.
Toggle Summary Xtant Medical to Present at the Canaccord Musculoskeletal Conference on March 7, 2023
BELGRADE, Mont. , Feb. 28, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne , Chief Executive Officer, will present at the Canaccord
Upcoming Events
There are currently no events scheduled.

Receive Email Alerts

Sign up to receive email alerts whenever Xtant Medical Holdings Inc posts new information to the site. Just enter your email address and click Submit.